All Cases

Market And Commercial Advanced Analytics

Estimated NSCLC burden in Mexico based on RWE to inform clinical management and drive market share of more effective therapies

Assessed the burden of inherited retina diseases to provide several emerging markets with policy-informing data and financial models to raise awareness of the burden of these diseases

Evaluated emerging markets for a large pharma client to understand specific health system support strategies required to successfully manage a new multiple sclerosis treatment